Humanized Antibody Molecules Specific for IL-31
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 8 of these applications claim priority to application 61/012,362, filed Dec 7, 2007. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 8,685,669 | Nucleic Acid Molecules Encoding Humanized Antibody Molecules Specific for IL-31 In force · High confidence | Merck Serono S/A | In force | High confidence | ||
| US 9,005,921 | Polynucleotides Encoding IL-31 Monoclonal Antibodies In force · Medium confidence | Merck Serono S/A | In force | Medium confidence | ||
| US 9,416,184 | Method of Treating Pruritus with IL-31 Monoclonal Antibodies In force · High confidence | Merck Serono S/A | In force | High confidence | ||
| US 9,738,715 | IL-31 Monoclonal Antibody Formulations In force · High confidence | Merck Serono S/A | In force | High confidence | ||
| US 9,982,044 | Method of Treating Pruritus with IL-31 Monoclonal Antibody Formulations In force · High confidence | Merck Serono S/A | In force | High confidence | ||
| US 11,542,327 | Methods of Treating Pruritic Disease with IL-31 Monoclonal Antibodies In force · High confidence | Merck Serono S/A | In force | High confidence | ||
| US 10,640,559 | Nucleic Acid Molecules Encoding Humanized IL-31 Monoclonal Antibodies In force · High confidence | Merck Serono S/A | In force | High confidence | ||
| US 8,470,979 | Humanized Antibody Molecules Specific for IL-31 In force · High confidence | ZymoGenetics, Inc. | In force | High confidence |
8 of 8 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.